Skip to main contentSkip to navigation
Sirius Investors
Arcus Biosciences, Inc.

Arcus Biosciences, Inc.

RCUS
NYSEHealthcare

Revenue Analysis - RCUS

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

RCUS Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

License And Development Services

0.0% of total revenue

$12.0M

Other Collaboration Revenue

0.0% of total revenue

$5.0M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
License And Development Services
License and Development Services Revenue
Other Collaboration Revenue
3/31/2026$12.0M$0$5.0M
12/31/2025$0$0$18.0M
9/30/2025$0$20.0M$6.0M
6/30/2025$0$152.0M$8.0M
3/31/2025$0$20.0M$8.0M
12/31/2024$0$0$19.0M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Declining Segments
Other Collaboration Revenue-72.2%

Earnings Reports

Want to see how RCUS's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports